Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...
A day after Emma Hayes dropped a 24-player roster for the upcoming April friendlies against Brazil, an additional U23 roster ...
ST316, a β-catenin/BCL9 antagonist, demonstrated safety, target engagement, and early antitumor activity in advanced solid ...
Cancer remains a leading cause of death globally, with lung cancer being particularly lethal. Despite advancements in diagnostics and therapies, the ...
Mansfield News Journal on MSN20h
Taylor Huff gets call for USWNT U-23 Training CampOn Wednesday, 2021 Madison grad and professional soccer player for Bay FC, Taylor Huff, received noticed that she has been ...
GlobalData on MSN2d
Surrozen drops hepatitis drug after Phase I flopSurrozen said despite SZN-043 demonstrating changes in liver function assays, there was not enough clinical benefit for ...
All Penny Stocks (English) on MSN20h
Micro Cap Soars Following Preliminary Data UpdateReal-time index price for DJ Brent Crude Index (BBR), along with buy or sell indicators, analysis, charts, historical ...
Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...
News-Medical.Net on MSN1d
New insights into therapy resistance in breast cancerA new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...
Innovations in therapeutic strategies, coupled with a deeper understanding of breast cancer biology, will be essential for advancing personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback